TKIs in Sarcoma
Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma

Released: November 02, 2021

Expiration: November 01, 2022

Activity

Progress
1
Course Completed
In this podcast episode, Jean-Yves Blay, MD, PhD, and Robin L. Jones, BSc, MBBS, MRCP, MD(Res), discuss the most important clinical trial data on leveraging TKIs as monotherapy and in combination with chemotherapy or immune checkpoint inhibitors for treatment of soft tissue sarcoma and osteosarcoma.